DRUG · Unmapped registry intervention
Ziprasidone oral capsules
Find medicine records ·
Find other trials using this name
Clinical trial
Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
NCT00265382
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedSafety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Interventions
Sponsors & collaborators
Mapped research locations
MoscowRussia4BirminghamAlabama, United States3CincinnatiOhio, United States3Kuala LumpurMalaysia3Oklahoma CityOklahoma, United States2SingaporeSingapore2LimaPeru2SaratovRussia2St LouisMissouri, United States1ClevelandOhio, United States1San DiegoCalifornia, United States1Washington D.C.District of Columbia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00265382 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.